Drugs / Dihydroxycholecalciferols
Dihydroxycholecalciferols
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT05560919 | Sep 2021 → Apr 2022 | — | Latakia University | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Dihydroxycholecalciferols | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05560919 ↗ |
| Known as | 1,25 DHC | “Local periodontal injection of 1,25 DHC at weekly interval (3 times).” NCT05560919 ↗ |
| Known as | 1.25 dihidroxicolecalciferol | “Vitamin D3 (Calcitriol or 1,25 Dihidroxicolecalciferol)” NCT05560919 ↗ |
| Known as | calcitriol | “Vitamin D3 (Calcitriol or 1,25 Dihidroxicolecalciferol)” NCT05560919 ↗ |
| Known as | Vitamin D3 | “Vitamin D3 (Calcitriol or 1,25 Dihidroxicolecalciferol)” NCT05560919 ↗ |